Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rupa Narayan, M.D.

Concepts (74)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute8202435891.410 Why?
Myelodysplastic Syndromes4202413760.900 Why?
Cytokine-Induced Killer Cells1201960.680 Why?
Myeloproliferative Disorders320226180.670 Why?
Hematopoietic Stem Cell Transplantation3202355510.490 Why?
HLA Antigens1201913340.450 Why?
Antigen Presentation1201912370.450 Why?
Immunoconjugates120198650.410 Why?
Antigens, Neoplasm1201919890.380 Why?
Tissue Donors1201922280.340 Why?
Nuclear Proteins2202357850.310 Why?
Hematologic Neoplasms1201918640.280 Why?
Antineoplastic Combined Chemotherapy Protocols22019115870.280 Why?
Leukemia, Myelomonocytic, Chronic12023930.210 Why?
Recurrence4202384200.210 Why?
Multiple Myeloma1202051100.210 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma2202215170.200 Why?
Antineoplastic Agents12024135500.180 Why?
Mitoxantrone120191500.170 Why?
Philadelphia Chromosome120201150.170 Why?
Maximum Tolerated Dose220198710.170 Why?
Azacitidine220233360.160 Why?
Disease-Free Survival2201967800.160 Why?
Etoposide120196260.150 Why?
Cytarabine120196960.150 Why?
Frameshift Mutation120193880.150 Why?
Antifungal Agents120207110.130 Why?
Eosinophilia120205560.130 Why?
BH3 Interacting Domain Death Agonist Protein12015880.130 Why?
Retreatment120156000.110 Why?
Silymarin12013440.110 Why?
Drug Administration Schedule1201948760.100 Why?
Phosphatidylcholines120134060.100 Why?
Thalidomide120158830.090 Why?
Graft vs Host Disease1202229640.090 Why?
Genotype12023128690.080 Why?
Chronic Disease1202391620.080 Why?
Humans1620247524110.080 Why?
Adult620232169270.070 Why?
Aged520201665850.070 Why?
Antibodies, Monoclonal1202391010.070 Why?
Middle Aged620202170390.070 Why?
Proteomics1201937510.070 Why?
Antioxidants1201316510.060 Why?
Bone Marrow1201529020.060 Why?
Aged, 80 and over32020582990.060 Why?
In Situ Hybridization, Fluorescence2202224950.060 Why?
Drug Resistance, Neoplasm1201951640.060 Why?
Survival Rate12019127450.060 Why?
Male720223549080.050 Why?
Retrospective Studies22023791330.050 Why?
Oncogene Proteins, Fusion2202215720.050 Why?
Neoplasms22021218060.050 Why?
Nuclear Pore Complex Proteins120221580.050 Why?
Female520203860850.050 Why?
Carcinoma, Hepatocellular1201322690.050 Why?
Antimetabolites, Antineoplastic120236360.040 Why?
Age Factors12015182980.040 Why?
Genetic Predisposition to Disease12019176470.040 Why?
Liver Neoplasms1201342710.040 Why?
Young Adult22020576320.030 Why?
Antibodies1202324120.030 Why?
Treatment Outcome22023642500.030 Why?
Cardiovascular Diseases12019156220.030 Why?
Pyrazoles1202019840.020 Why?
Pyrimidines1202029790.020 Why?
Immunotherapy1202246010.020 Why?
Incidence12020211570.010 Why?
Dose-Response Relationship, Drug12013107960.010 Why?
Prognosis12019293370.010 Why?
Risk Assessment12019237880.010 Why?
Disease Progression12013134050.010 Why?
Mutation12019297060.010 Why?
Risk Factors12019734250.010 Why?
Narayan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (74)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.